BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3285902)

  • 1. Platelet MAO activity in hallucinating and paranoid schizophrenics: a review and meta-analysis.
    Zureick JL; Meltzer HY
    Biol Psychiatry; 1988 May; 24(1):63-78. PubMed ID: 3285902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactions.
    Meltzer HY; Zureick JL
    Psychiatry Res; 1987 Oct; 22(2):99-109. PubMed ID: 3685225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
    Meltzer HY; Arora RC; Jackman H; Pscheidt G; Smith MD
    Schizophr Bull; 1980; 6(2):213-9. PubMed ID: 7375852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD; Potkin SG; Wise CD; Bridge TP; Neckers LM; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):179-85. PubMed ID: 298347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are paranoid schizophrenics biologically different from other schizophrenics?
    Potkin SG; Cannon HE; Murphy DL; Wyatt RJ
    N Engl J Med; 1978 Jan; 298(2):61-6. PubMed ID: 619236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics.
    Mann JJ; Kaplan RD; Georgotas A; Friedman E; Branchey M; Gershon S
    Psychopharmacology (Berl); 1981; 74(4):344-8. PubMed ID: 6794079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM
    Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet monoamine oxidase and clinical phenomenology of schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Psychiatry Res; 1984 Mar; 11(3):205-9. PubMed ID: 6587413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood tryptophan metabolism in chronic schizophrenics.
    Freedman DX; Belendiuk K; Belendiuk GW; Crayton JW
    Arch Gen Psychiatry; 1981 Jun; 38(6):655-9. PubMed ID: 7247628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of platelet monoamine oxidase activity and phosphatidylserine content between chronic paranoid schizophrenics and normal controls.
    Orologas AG; Buckman TD; Eiduson S
    Neurosci Lett; 1986 Aug; 68(3):293-8. PubMed ID: 3748456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups.
    Wise CD; Bridge TP; Potkin SG; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.
    Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R
    Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
    Mann J; Thomas KM
    Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet monoamine oxidase in chronic schizophrenic patients.
    Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.
    Schildkraut JJ; Herzog JM; Orsulak PJ; Edelman SE; Shein HM; Frazier SH
    Am J Psychiatry; 1976 Apr; 133(4):438-40. PubMed ID: 1267046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase (MAO) of platelets, plasma, lymphocytes and granulocytes in schizophrenia.
    Bond PA; Cundall RL; Falloon IR
    Br J Psychiatry; 1979 Apr; 134():360-5. PubMed ID: 444786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet monoamine oxidase in schizophrenia: a meta-analysis.
    Marcolin MA; Davis JM
    Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.